Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Cytotherapy|January 29, 2023
Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineeringOrly R Klein, Carmem Bonfim, Allistair Abraham, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 7, 2026
Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell DiseaseDiego R Hijano, Caitlin Elgarten, Elizabeth Stenge, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2015
Using fludarabine to reduce exposure to alkylating agents in children with sickle cell disease receiving busulfan, cyclophosphamide, and antithymocyte globulin transplant conditioning: results of a dose de-escalation trialJohn T Horan, Ann Haight, Jacqueline Lagerlof Dioguardi, et al.Cytotherapy|September 25, 2024
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committeeJoseph H Oved, Athena Russell, Amy DeZern, et al.Cytotherapy|July 6, 2024
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges facedAshish O Gupta, Melissa Azul, Senthil Velan Bhoopalan, et al.Transplantation and Cellular Therapy|July 7, 2024
Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell TransplantationSobenna A George, Anirudh Veludhandi, Yijin Xiang, et al.Cytotherapy|March 20, 2023
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantMoises Garcia-Rosa, Allistair Abraham, Alice Bertaina, et al.Transplantation and Cellular Therapy|June 21, 2025
Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for HemoglobinopathyNiketa C Shah, Alexander Ngwube, Tara Suresh, et al.Transplantation and Cellular Therapy|December 27, 2021
Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell DiseaseNiketa C Shah, Sweta Bhoopatiraju, Allistair Abraham, et al.American Journal of Hematology|August 6, 2024
Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysisStaci D Arnold, Nitya Bakshi, Diana Ross, et al.Pageof 5